July 11, 2014 4:31 PM ET

Capital Markets

Company Overview of Quaker BioVentures

Executive Profile

Matthew Rieke M.D.

Former Director, TransEnterix, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 7 different industries.

See Board Relationships
----

Background

Dr. Matthew Rieke, also known as Matt, M.D. serves as a Director of Transport Pharmaceuticals, Inc., Kolis Scientific, Neotropix, Inc., Nitric Bio, Inc., Tarsa Therapeutics, Inc. and TearScience, Inc. He served as a Director of TransEnterix, Inc. since October 2009. He serves as a Board Observer of Neuronetics. Dr. Rieke is a Director of Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm. He was appointed a Director at Ben Franklin on December ...

Corporate Headquarters

2929 Arch Street
Philadelphia, Pennsylvania 19104-2868

United States

Phone: 215-988-6800
Fax: 215-988-6801

Board Members Memberships

Director and Member of Life Sciences Investment Advisory Committee
Director
Director
Director
Director
Director
2009-N/A
Former Director

Education

BA
Colgate University
MBA
University of Pennsylvania - The Wharton School
Doctorate
University of Pennsylvania - School of Medicine
MD
University of Pennsylvania - School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gary S. Guthart Ph.D.Chief Executive Officer, President and Director
Intuitive Surgical, Inc.
$560.0K
Kevin A. Lobo Chief Executive Officer, President and Director
Stryker Corporation
$1.0M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
José E. Almeida Chairman, Chief Executive Officer and President
Covidien plc
$1.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Quaker BioVentures, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.